ADPT
Adaptive Biotechnologies Corp
+1.03 (+3.72%)28.70USD1.5M成交股數4.6B市值–本益比(近四季)14.9股價營收比+21.5%營收年增(近四季)2026-11-04下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 26 · 47.7M · 9 |
| 其中 10b5-1 計畫賣出 | 16 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 59.9M |
| 近 180 天 淨額 | −59.9M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 | 09-02 | OWEN KATEY EINTERZ | Director | G 贈與 | 12.5K | – | – | 66.1K | SEC |
| 2026-08-26 | 08-28 | OWEN KATEY EINTERZ | Director | S 公開市場賣出 | 9.6K | 26.00 | 250K | 78.6K | SEC |
| 2026-08-18 | 08-20 | HERSHBERG ROBERT | Director | S 公開市場賣出 | 15.0K | 24.39 | 366K | 62.3K | SEC |
| 2026-08-18 | 08-20 | HERSHBERG ROBERT | Director | M 選擇權執行 | 15.0K | 6.32 | 95K | 77.3K | SEC |
| 2026-08-18 | 08-20 | HERSHBERG ROBERT | Director | S 公開市場賣出 | 15.7K | 24.41 | 382K | 46.7K | SEC |
| 2026-08-18 | 08-19 | ROBINS CHAD M | CEO and Chairman | S 公開市場賣出 | 278K | 24.48 | 6.8M | 2.2M | SEC |
| 2026-08-18 | 08-19 | ROBINS CHAD M | CEO and Chairman | M 選擇權執行 | 279K | 6.55 | 1.8M | 2.5M | SEC |
| 2026-08-18 | 08-19 | ROBINS CHAD M | CEO and Chairman | S 公開市場賣出 | 204 | 25.14 | 5K | 2.2M | SEC |
| 2026-08-17 | 08-19 | NEUPERT PETER M | Director | S 公開市場賣出 | 40.0K | 25.10 | 1.0M | 200K | SEC |
| 2026-08-17 | 08-19 | NEUPERT PETER M | Director | S 公開市場賣出 | 15.0K | 25.23 | 378K | 240K | SEC |
| 2026-08-17 | 08-19 | ROBINS CHAD M | CEO and Chairman | S 公開市場賣出 | 319K | 25.08 | 8.0M | 2.2M | SEC |
| 2026-08-17 | 08-19 | ROBINS CHAD M | CEO and Chairman | S 公開市場賣出 | 2.5K | 25.57 | 65K | 2.2M | SEC |
| 2026-08-17 | 08-19 | ROBINS CHAD M | CEO and Chairman | M 選擇權執行 | 321K | 6.55 | 2.1M | 2.5M | SEC |
| 2026-08-17 | 08-19 | NEUPERT PETER M | Director | M 選擇權執行 | 15.0K | 6.32 | 95K | 255K | SEC |
| 2026-08-17 | 08-19 | NEUPERT PETER M | Director | S 公開市場賣出 | 69.7K | 25.16 | 1.8M | 131K | SEC |
| 2026-08-10 | 08-12 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 3.0K | 25.00 | 75K | 397K | SEC |
| 2026-07-30 | 08-03 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 1.3K | 24.00 | 31K | 400K | SEC |
| 2026-07-21 | 07-23 | ROBINS HARLAN S | Chief Scientific Officer | M 選擇權執行 | 285K | 6.55 | 1.9M | 1.3M | SEC |
| 2026-07-21 | 07-23 | ROBINS HARLAN S | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 279K | 21.72 | 6.1M | 1.0M | SEC |
| 2026-07-21 | 07-23 | ROBINS HARLAN S | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 214K | 22.12 | 4.7M | 812K | SEC |
| 2026-07-16 | 07-20 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 5.0K | 23.00 | 115K | 401K | SEC |
| 2026-07-15 | 07-17 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 22.7K | 8.46 | 192K | 336K | SEC |
| 2026-07-15 | 07-17 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 59.4K | 7.80 | 463K | 290K | SEC |
| 2026-07-15 | 07-17 | LO FRANCIS | Chief People Officer | S 公開市場賣出(10b5-1) | 106K | 22.59 | 2.4M | 231K | SEC |
| 2026-07-15 | 07-17 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 23.7K | 12.14 | 287K | 314K | SEC |
| 2026-07-02 | 07-07 | ROBINS HARLAN S | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 239K | 21.74 | 5.2M | 1.2M | SEC |
| 2026-07-02 | 07-07 | ROBINS HARLAN S | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 147K | 22.45 | 3.3M | 1.0M | SEC |
| 2026-07-02 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 12.6K | 8.46 | 107K | 276K | SEC |
| 2026-07-02 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 12.6K | 7.80 | 98K | 250K | SEC |
| 2026-07-02 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 12.6K | 12.14 | 153K | 263K | SEC |
| 2026-07-02 | 07-06 | LO FRANCIS | Chief People Officer | S 公開市場賣出(10b5-1) | 44.8K | 22.59 | 1.0M | 231K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 12.2K | 8.46 | 103K | 270K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 3.3K | 12.14 | 40K | 258K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 3.5K | 7.80 | 27K | 254K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 4.7K | 3.99 | 19K | 275K | SEC |
| 2026-07-01 | 07-06 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 487 | 22.00 | 11K | 406K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | S 公開市場賣出(10b5-1) | 42.3K | 22.50 | 951K | 238K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 14.1K | 8.12 | 114K | 289K | SEC |
| 2026-07-01 | 07-06 | LO FRANCIS | Chief People Officer | S 公開市場賣出(10b5-1) | 8.7K | 22.18 | 194K | 280K | SEC |
| 2026-06-29 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M 選擇權執行 | 24.9K | 3.99 | 100K | 324K | SEC |
| 2026-06-29 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M 選擇權執行 | 51.6K | 8.12 | 419K | 376K | SEC |
| 2026-06-29 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M 選擇權執行 | 1.8K | 12.14 | 22K | 275K | SEC |
| 2026-06-29 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M 選擇權執行 | 24.9K | 8.46 | 211K | 300K | SEC |
| 2026-06-29 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S 公開市場賣出(10b5-1) | 155K | 21.14 | 3.3M | 221K | SEC |
| 2026-06-26 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | S 公開市場賣出(10b5-1) | 11.0K | 21.00 | 232K | 273K | SEC |
| 2026-06-26 | 06-30 | BENZENO SHARON | Chief Commercial Ofc Imm Med | M 選擇權執行 | 11.0K | 12.14 | 134K | 284K | SEC |
| 2026-06-25 | 06-29 | GRIFFIN MICHELLE RENEE | Director | M 選擇權執行 | 52.1K | 7.80 | 406K | 67.7K | SEC |
| 2026-06-25 | 06-29 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 5.0K | 20.50 | 103K | 407K | SEC |
| 2026-06-25 | 06-29 | GRIFFIN MICHELLE RENEE | Director | S 公開市場賣出(10b5-1) | 52.1K | 20.18 | 1.1M | 15.6K | SEC |
| 2026-06-16 | 06-17 | ROBINS HARLAN S | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 6.2K | 18.01 | 111K | 1.4M | SEC |
| 2026-06-15 | 06-17 | ROBINS HARLAN S | Chief Scientific Officer | S 公開市場賣出(10b5-1) | 100K | 17.37 | 1.7M | 1.4M | SEC |
| 2026-06-11 | 06-15 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 5.0K | 19.00 | 95K | 412K | SEC |
| 2026-06-04 | 06-08 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 5.8K | 12.14 | 70K | 277K | SEC |
| 2026-06-04 | 06-08 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 2.0K | 8.46 | 17K | 279K | SEC |
| 2026-06-04 | 06-08 | BOBULSKY SUSAN | Chief Commercial Officer, MRD | S 公開市場賣出(10b5-1) | 11.0K | 18.00 | 198K | 417K | SEC |
| 2026-06-04 | 06-08 | LO FRANCIS | Chief People Officer | S 公開市場賣出(10b5-1) | 39.7K | 17.49 | 695K | 251K | SEC |
| 2026-06-04 | 06-08 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 9.4K | 8.12 | 76K | 291K | SEC |
| 2026-06-04 | 06-08 | LO FRANCIS | Chief People Officer | M 選擇權執行 | 2.3K | 3.99 | 9K | 281K | SEC |
| 2026-05-18 | 05-20 | PISKEL KYLE | Chief Financial Officer | S 公開市場賣出 | 3.1K | 13.04 | 41K | 257K | SEC |
| 2026-04-27 | 04-29 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.0K | 14.23 | 271K | 378K | SEC |
| 2026-04-27 | 04-29 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 124K | 397K | SEC |
| 2026-04-24 | 04-24 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 401K | SEC |
| 2026-04-24 | 04-24 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.02 | 267K | 382K | SEC |
| 2026-04-23 | 04-24 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 13.74 | 262K | 386K | SEC |
| 2026-04-23 | 04-24 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 406K | SEC |
| 2026-04-22 | 04-24 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.13 | 269K | 391K | SEC |
| 2026-04-22 | 04-24 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 410K | SEC |
| 2026-04-21 | 04-21 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 11.9K | 12.14 | 144K | 426K | SEC |
| 2026-04-21 | 04-21 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 414K | SEC |
| 2026-04-21 | 04-21 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 30.9K | 14.66 | 454K | 395K | SEC |
| 2026-04-20 | 04-21 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 419K | SEC |
| 2026-04-20 | 04-21 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.55 | 277K | 399K | SEC |
| 2026-04-17 | 04-21 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.57 | 278K | 404K | SEC |
| 2026-04-17 | 04-21 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 423K | SEC |
| 2026-04-16 | 04-16 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.18 | 270K | 408K | SEC |
| 2026-04-16 | 04-16 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 427K | SEC |
| 2026-04-15 | 04-16 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.61 | 278K | 412K | SEC |
| 2026-04-15 | 04-16 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 432K | SEC |
| 2026-04-14 | 04-16 | RUBINSTEIN JULIE | President and COO | S 公開市場賣出(10b5-1) | 19.1K | 14.56 | 278K | 417K | SEC |
| 2026-04-14 | 04-16 | RUBINSTEIN JULIE | President and COO | M 選擇權執行 | 14.7K | 8.46 | 125K | 436K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 維京環球 VIKING GLOBAL INVESTORS LP | 30.0M | 643M | 新進 | 新進 |
| BlackRock, Inc. | 15.1M | 325M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.4M | 137M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.9M | 127M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.5M | 117M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 4.6M | 99.2M | 新進 | 新進 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.3M | 91.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.6M | 78.1M | 新進 | 新進 |
| STATE STREET CORP | 3.5M | 74.2M | 新進 | 新進 |
| Invesco Ltd. | 3.1M | 66.4M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 3.0M | 64.0M | 新進 | 新進 |
| Driehaus Capital Management LLC | 2.5M | 54.2M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.5M | 54.2M | 新進 | 新進 |
| Nuveen, LLC | 2.4M | 50.8M | 新進 | 新進 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2.2M | 46.8M | 新進 | 新進 |
| FRED ALGER MANAGEMENT, LLC | 2.1M | 44.9M | 新進 | 新進 |
| 方舟(伍德) ARK Investment Management LLC | 2.1M | 44.8M | 新進 | 新進 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.9M | 40.5M | 新進 | 新進 |
| Aristotle Atlantic Partners, LLC | 1.8M | 39.4M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 1.7M | 37.1M | 新進 | 新進 |
| JANE STREET GROUP, LLC | 1.6M | 34.1M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.5M | 32.3M | 新進 | 新進 |
| Sumitomo Mitsui Trust Group, Inc. | 1.3M | 28.5M | 新進 | 新進 |
| Amova Asset Management Americas, Inc. | 1.3M | 28.5M | 新進 | 新進 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.3M | 27.0M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 300 +2 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 300 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 156M · 97.6% |
| 合計季末市值 | 3.2B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 11.7M |
|---|---|
| 與上期比 | -12.1% |
| 佔流通股數 | 7.34% |
| 日均成交量 | 1.8M |
| 回補天數 | 6.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 11.7M | -12.1% | 7.34% | 1.8M | 6.4 |
| 2026-08-14 | 13.3M | +6.7% | 8.35% | 2.3M | 5.7 |
| 2026-07-31 | 12.5M | +9.6% | 7.83% | 2.8M | 4.4 |
| 2026-07-15 | 11.4M | +0.4% | 7.14% | 2.6M | 4.3 |
| 2026-06-30 | 11.4M | +48.5% | 7.11% | 5.1M | 2.2 |
| 2026-06-15 | 7.6M | -7.2% | 4.79% | 2.7M | 2.8 |
| 2026-05-29 | 8.2M | -7.4% | 5.16% | 1.6M | 5.1 |
| 2026-05-15 | 8.9M | +5.4% | 5.57% | 2.0M | 4.6 |
| 2026-04-30 | 8.4M | -1.3% | 5.29% | 1.2M | 6.9 |
| 2026-04-15 | 8.6M | -0.1% | 5.36% | 1.9M | 4.4 |
| 2026-03-31 | 8.6M | -7.4% | 5.36% | 2.1M | 4.1 |
| 2026-03-13 | 9.2M | +4.2% | 5.79% | 2.5M | 3.7 |
| 2026-02-27 | 8.9M | -3.4% | 5.56% | 1.4M | 6.5 |
| 2026-02-13 | 9.2M | +1.8% | 5.76% | 2.2M | 4.3 |
| 2026-01-30 | 9.0M | +0.1% | 5.66% | 1.6M | 5.6 |
| 2026-01-15 | 9.0M | +3.0% | 5.65% | 2.2M | 4.0 |
| 2025-12-31 | 8.8M | -10.1% | 5.49% | 2.0M | 4.4 |
| 2025-12-15 | 9.7M | -6.3% | 6.10% | 3.3M | 2.9 |
| 2025-11-28 | 10.4M | +0.3% | 6.52% | 2.8M | 3.8 |
| 2025-11-14 | 10.4M | +15.1% | 6.50% | 2.1M | 5.0 |
| 2025-10-31 | 9.0M | -0.2% | 5.65% | 1.5M | 5.8 |
| 2025-10-15 | 9.0M | -5.9% | 5.66% | 1.8M | 5.0 |
| 2025-09-30 | 9.6M | +2.6% | 6.01% | 2.1M | 4.7 |
| 2025-09-15 | 9.3M | +10.8% | 5.86% | 1.9M | 5.0 |
| 2025-08-29 | 8.4M | -5.8% | 5.28% | 1.7M | 4.9 |
| 2025-08-15 | 8.9M | -9.9% | 5.60% | 2.6M | 3.4 |